Peptide GuideBronchogen

The Peptide Guide

All healing & recovery peptides

Bronchogen

Lung supportRecovery

Bronchogen is a short Khavinson bioregulator (AEDL) studied as a signal for bronchial tissue. Western trial data is limited.

What does it do?

Signals gene activity in bronchial lining cells
Supports the airway surface that handles mucus and air flow
Used for chest and lung comfort, not athletic output
Run in short cycles instead of daily year-round use
Does not dilate airways the way a rescue inhaler does
The effect is regulatory and quiet across the cycle

How does it work?

A short peptide aimed at lung and airway gene signaling
Studied as a tissue-specific bioregulator, not a bronchodilator drug
Works over a 10 to 20 day course
Does not open airways the way albuterol does
Delivers a regulatory effect rather than a rescue-inhaler feel
Evidence is mostly from the original Russian research line

What to expect?

The first doses do not open the chest like an inhaler
Any easier breathing shows up after the cycle, not after dose one
No stimulant rush
The chest can feel a little less reactive by the end
The effect stays quiet the whole way through

How it's typically administered

Oral capsulesOral capsulescommon in the original course style
Sub-Q injectionSubcutaneous injectionused with research vials
Intramuscular injectionIntramuscular injectionused with research vials

How it's typically dosed

Most common dose1–2 capsules
FrequencyOnce daily
Cycle duration10–20 days, 1–2 courses a year

BackAll healing & recovery peptides Full peptide list